Filing Details

Accession Number:
0001061983-21-000261
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-19 18:16:36
Reporting Period:
2021-11-19
Accepted Time:
2021-11-19 18:16:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1061983 Cytokinetics Inc CYTK Pharmaceutical Preparations (2834) 943291317
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1243004 D Sandford Smith 280 East Grand Avenue
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-19 5,000 $9.45 11,765 No 4 M Direct
Common Stock Disposition 2021-11-19 5,000 $41.21 6,765 No 4 S Direct
Common Stock Acquisiton 2021-11-19 20,000 $14.25 26,765 No 4 M Direct
Common Stock Disposition 2021-11-19 20,000 $41.21 6,765 No 4 S Direct
Common Stock Acquisiton 2021-11-19 4,032 $12.40 10,797 No 4 M Direct
Common Stock Disposition 2021-11-19 4,032 $41.21 6,765 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2021-11-19 5,000 $0.00 5,000 $9.45
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2021-11-19 4,032 $0.00 4,032 $12.40
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2021-11-19 20,000 $0.00 20,000 $14.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-06-16 2028-05-16 No 4 M Direct
0 2017-02-03 2027-01-03 No 4 M Direct
0 2017-06-18 2027-05-18 No 4 M Direct
Footnotes
  1. Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.